Best IV options for headache (acute migraine) - based on current evidence
The strongest, most current evidence comes from the 2025 American Headache Society (AHS) guideline update on parenteral pharmacotherapies for acute migraine in the ED (Robblee et al., Headache, 2026; PMID 41321235), which reviewed 26 new RCTs across 20 injectable treatments. Recommendations:
Must offer (Level A - strongest evidence):
- Prochlorperazine IV (10 mg) - highly likely effective, backed by multiple class I trials
- Greater occipital nerve block (not a drug, but a procedure) - also Level A
Must NOT offer (Level A):
- Hydromorphone IV - opioids are ineffective/harmful for migraine and should be avoided
Should offer (Level B):
- Dexketoprofen IV
- Ketorolac IV (NSAID, typically 30 mg)
- Metoclopramide IV (10 mg) - also highly likely effective, one of the most studied agents
- Sumatriptan SC (subcutaneous, not IV)
May offer (Level C):
- Chlorpromazine IV, dexamethasone IV (helps prevent headache recurrence after discharge, not acute relief), valproate IV
Should not offer:
- Paracetamol (acetaminophen) IV
Practical bottom line
For an adult in the ED with a moderate-to-severe migraine and no contraindications, the best evidence-supported first-line IV combination is:
- Prochlorperazine 10 mg IV or metoclopramide 10 mg IV (dopamine antagonist/antiemetic)
- plus diphenhydramine 25 mg IV (reduces akathisia risk from the antiemetic)
- plus ketorolac 30 mg IV (NSAID)
- with IV fluids (normal saline bolus) if the patient is volume-depleted from vomiting
This is corroborated by Rosen's Emergency Medicine and Tintinalli's Emergency Medicine, which list IV metoclopramide/prochlorperazine, IV ketorolac, and IV dihydroergotamine as core options, while explicitly noting opioids are not recommended as first-line therapy - Tintinalli's Emergency Medicine, Table 165-7; Rosen's Emergency Medicine, Management of Migraine.
Second-line/refractory cases: IV magnesium sulfate (1 g), IV dihydroergotamine (with an antiemetic pretreatment), or IV valproate can be considered, especially in status migrainosus - Adams and Victor's Principles of Neurology, 12th Ed., "Status Migrainosus."
Special notes:
- In pregnancy, the Canadian Headache Society guidelines advise against dexamethasone, magnesium sulfate, tramadol, and acetaminophen; IV methylprednisolone is a reasonable alternative for severe/status migrainosus - Bradley and Daroff's Neurology in Clinical Practice.
- In children/adolescents, IV metoclopramide and IV ketorolac (preferred over IV valproate) are supported, with IV magnesium reserved for treatment failures.
- Adding a one-time dose of IV dexamethasone before discharge reduces headache recurrence in the following 24-72 hours (~10% absolute risk reduction), though it doesn't treat the acute attack itself.
A caveat on "headache" generally
If the headache isn't migraine (e.g., cluster headache, tension headache, or a secondary headache from something like meningitis, subarachnoid hemorrhage, or elevated intracranial pressure), the "best IV" changes completely - the answer above applies specifically to acute migraine. If you're asking about a specific headache type or a specific clinical scenario, let me know and I can narrow this down further.
Recent network meta-analyses (PMID 39674934, PMID 38644702, PMID 37849443) support these rankings and largely echo the same hierarchy: prochlorperazine, metoclopramide, and NSAIDs among the most effective and safe; opioids among the least favorable due to poor efficacy and rebound/dependency risk.